Heme Arginate in Transplantation Study

NCT03646344 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

47

Enrollment

OTHER

Sponsor class

Stopped COVID

Conditions

Renal Transplant Rejection
Renal Transplant Failure

Interventions

DRUG: Heme Arginate 25 MG/ML
DRUG: 0.9% Sodium-chloride

Sponsor

University of Edinburgh

Collaborators

[object Object]